DPP4 and Alzheimer disease: On the other hand, when compared with other anti-diabetic drugs such as metformin and DPP4 inhibitors in observational studies that correlated these treatments with the risk of AD, glucosidase enzyme inhibitors are less significant in lowering the AD risk [153, 159].